Interestingly, there are some data supporting that ATM variant carriers diagnosed with pancreatic ductal adenocarcinoma could have longer survival [48, 50], and both ATM variants here identified were found in two long responding patients diagnosed with melanoma and pancreatic cancer, respectively. This evidence concerns the gene ATM and melanoma.